http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2006104226-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-985
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C249-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-0239
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C249-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-36
filingDate 2006-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-WO2006104226-A1
titleOfInvention Optically active quaternary ammonium salt having axial asymmetry and method for producing α-amino acid and derivatives thereof using the same
abstract The present invention relates to a chiral phase transfer catalyst of the following formula (I): I will provide a. This compound (I) can be produced by reacting a 2,2′-dimethylenebromide-1,1′-biphenyl derivative, which can be produced with relatively few steps, with a readily available secondary amine.
priorityDate 2005-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004359578-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006093269-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002326992-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12655209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57931698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12481439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57931703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421637471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425112209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424308017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467908603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424308020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468011527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID622362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465691129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466539853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15983120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414609864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467145091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414448063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10996557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57931692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152861361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411431452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414529538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57931693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466866826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15983252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414940587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20758550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465951730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433244569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410578617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422576118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467421441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465120590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15832869

Total number of triples: 56.